je.st
news
Tag: johnson
Mead Johnson launches Enfinitas product line in China
2016-03-31 01:00:00| Food Processing Technology
Mead Johnson Nutrition Company has announced the launch of its new Enfinitas premium-priced product range in China, which will address the growing demand for foreign brands of infant milk after the 2008 tainted milk scandal.
Tags: line
product
china
johnson
Daisy Johnson Has a Vision of the Future in New Agents of SHIELD Photos
2016-03-29 16:29:14| Toys - Topix.net
ABC and Marvel Entertainment have released the first batch of photos from episode 3.15 of Marvel's Agents of SHIELD which you can check out in the gallery below! "When Daisy gets a horrifying glimpse of the future, S.H.I.E.L.D. races to prove that fate is not fixed." The Marvel's Agents of SHIELD cast includes Clark Gregg as Director Phil Coulson, Ming-Na Wen as Agent Melinda May, Brett Dalton as Grant Ward, Chloe Bennet as Agent Daisy Johnson, Iain De Caestecker as Agent Leo Fitz, Elizabeth Henstridge as Agent Jemma Simmons, Nick Blood as Agent Lance Hunter, Adrianne Palicki as Agent Bobbi Morse, Henry Simmons as Agent Alphonso "Mack" MacKenzie and Luke Mitchell as Lincoln Campbell.
Johnson & Johnson's Outlook
2016-03-29 13:57:34| Biotech - Topix.net
It's time to take a look at Johnson & Johnson's valuation again, because I like to review all of my long-term stock holdings at least once per year. Currently, I am not holding a whole lot of value in the US stock market.
Tags: johnson
outlook
johnsons
johnson johnsons
Johnson & Johnson's Growing Drug Dependency Makes The Business More Unpredictable
2016-03-29 01:23:06| Biotech - Topix.net
J&J's strong Pharma performance over the past few years, coupled with tepid growth in Consumer Healthcare and Medical Devices, indicates a shift in basic revenue structure. The more they succeed at Pharma and lose growth in Consumer Healthcare, the greater their risk of unstable revenue growth.
Tags: business
makes
growing
drug
Johnson & Johnson (JNJ) Upgraded at Goldman Sachs
2016-03-27 03:18:04| Biotech - Topix.net
The firm currently has a $112.00 price objective on the stock, up from their previous price objective of $102.00. Goldman Sachs' price target indicates a potential upside of 3.41% from the stock's current price.
Tags: johnson
upgraded
goldman
sachs
Sites : [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] next »